J.M. Dogné
Natural and Synthetic Drug Research Center
University of Liège
Belgium
Name/email consistency: high
- From the design to the clinical application of thromboxane modulators. Dogné, J.M., Hanson, J., de Leval, X., Pratico, D., Pace-Asciak, C.R., Drion, P., Pirotte, B., Ruan, K.H. Curr. Pharm. Des. (2006)
- Coxibs and cardiovascular side-effects: from light to shadow. Dogné, J.M., Hanson, J., Supuran, C., Pratico, D. Curr. Pharm. Des. (2006)
- Adverse cardiovascular effects of the coxibs. Dogné, J.M., Supuran, C.T., Pratico, D. J. Med. Chem. (2005)
- Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig. Dogné, J.M., Rolin, S., Pétein, M., Tchana-Sato, V., Ghuysen, A., Lambermont, B., Hanson, J., Magis, D., Segers, P., Pirotte, B., Masereel, B., Drion, P., D'Orio, V., Kolh, P. Thromb. Res. (2005)
- Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis. Dogné, J.M., Hanson, J., Pratico, D. Trends Pharmacol. Sci. (2005)
- Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time. Dogné, J.M., Hanson, J., de Leval, X., Kolh, P., Tchana-Sato, V., de Leval, L., Rolin, S., Ghuysen, A., Segers, P., Lambermont, B., Masereel, B., Pirotte, B. J. Pharmacol. Exp. Ther. (2004)
- New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators. Dogné, J.M., de Leval, X., Hanson, J., Frederich, M., Lambermont, B., Ghuysen, A., Casini, A., Masereel, B., Ruan, K.H., Pirotte, B., Kolh, P. Curr. Med. Chem. (2004)
- New developments on thromboxane modulators. Dogné, J.M., Hanson, J., de Leval, X., Masereel, B., Kolh, P., Pirotte, B. Mini. Rev. Med. Chem (2004)
- Therapeutic potential of thromboxane inhibitors in asthma. Dogné, J.M., de Leval, X., Benoit, P., Rolin, S., Pirotte, B., Masereel, B. Expert. Opin. Investig. Drugs (2002)
- Recent advances in antiplatelet agents. Dogne, J.M., de Leval, X., Benoit, P., Delarge, J., Masereel, B., David, J.L. Curr. Med. Chem. (2002)
- Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531. Dogné, J.M., Rolin, S., de Leval, X., Benoit, P., Neven, P., Delarge, J., Kolh, P., Damas, J., David, J.L., Masereel, B. Cardiovasc. Drug. Rev (2001)
- New trends in thromboxane and prostacyclin modulators. Dogné, J.M., de Leval, X., Delarge, J., David, J.L., Masereel, B. Curr. Med. Chem. (2000)
- Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function. Dogné, J.M., de Leval, X., Neven, P., Rolin, S., Wauters, J., David, J.L., Delarge, J., Massereel, B. Prostaglandins Leukot. Essent. Fatty Acids (2000)